Giant Cell Arteritis Vasculitis syndromes: Tocilizumab — a new frontier for GCA therapy An unmet need exists for effective glucocorticoid-sparing agents for the treatment of giant cell arteritis (GCA). Tocilizumab, the first intervention to demonstrate substantial therapeutic benefits for… nature.com
